Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-66 of 66 for

Edit search filters
  1. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy

    Jacksonville, FL, Scottsdale/Phoenix, AZ

  2. Detection of Plasma DNA Methylation in Peripheral Blood from Patients with Hepatocellular Carcinoma

    Rochester, MN

  3. Hepatocellular Carcinoma Early Detection Strategy Study

    Rochester, MN

  4. A Study to Assess Multiparametric MR Elastography (MRE) in Diagnosing and Monitoring Cirrhosis or Hepatocellular Carcinoma (HCC) Patients

    Rochester, MN

  5. A Study To Develop A Resource (Bank) Of Biospecimens And Data Collected From Individuals With Liver Disease And Without Liver Disease

    Rochester, MN

  6. Detection of Circulating tumor cells (CTC) from Patients with Hepatocellular Carcinoma (HCC)

    Rochester, MN

.

Mayo Clinic Footer